Key Takeaways
- Volume-led 9.6% CC growth with margin expansion: Consolidated revenue grew 9.6% in constant currency, driven by 6% India FMCG volume growth, while gross margin expanded 310 bps on material deflation.
- Rural engine decisively outperformed urban: Rural growth of ~6-6.5% surpassed urban's ~3.8%, powered by distribution expansion into 17,000 more villages and a curated accessible-price-point portfolio, gaining 400 bps rural market share.
- A&P investment surged 36% to capture demand: Operating profit grew 9.5% with 50 bps margin improvement despite the A&P step-up; excluding exceptional legal costs, OP grew 13% with 120 bps margin expansion.
- Badshah and Hair Oil are the structural growth bets: Badshah grew 33% with a 2-3% market share leaving vast headroom; Hair Oil gained 140 bps share with only 16-17% category share, signaling a long runway.
- What to watch next quarter: Whether the winter-delayed Chyawanprash and Honey inventory liquidates without trade pushback, the pace of the promised faster Q4 margin expansion, and any signal on rural food inflation easing.
Demand & Volume Dynamics
- Volume-led growth as pricing decelerates: India FMCG volume grew 6% while pricing increases entered the base, making this a largely volume-driven quarter; management took ~2.5% MRP-led price increases with part flowing into Q4, and future increases depend on inflation trends.
- Rural outperformance built on distribution, not demand recovery: Rural growth of ~6-6.5% beat urban's ~3.8% because Dabur added 17,000 villages (now 1,17,000), 2 lakh direct-reach outlets, and 7,000 Yoddhas (network now 18,700), with a portfolio curated for accessible price points.
- Rural FMCG backdrop is still soft: Rural FMCG growth has declined for two quarters as double-digit food inflation in fruits, vegetables, spices and cereals squeezed discretionary spending; Dabur's gains are share gains, not category tailwinds.
- Urban share gains alongside rural: Urban growth, while lower in absolute terms, is ahead of category growth, with urban market share up 100 bps and rural up 400 bps.
- Winter-sensitive Healthcare products saw delayed offtake: Chyawanprash was flat and Honitus muted because winter arrived late and contracted; trade will liquidate stocks in Q4 but will not take more, so Q4 Healthcare loading may be lighter than typical.
Mohit Malhotra: "the gap between the urban and rural is reducing for last three quarters. We saw a gap between urban and rural of 800 basis points, it got reduced to 600, to 400. Now it is only 200 basis points, if you see. That is the difference. So, as the gap narrows between urban and rural with price going up, I think rural recovery is imminent to happen in the country for one or two quarters."
Portfolio Performance
| Category | Trend | Commentary |
|---|---|---|
| Oral Care | ▲ 8% value, 5% volume | Herbal toothpaste outpaced non-herbal by ~200 bps, reaching 31% share; Meswak grew double digits; Bae Fresh gel launched at ~Rs. 17 cr turnover, ~1-1.5% gel share. |
| Hair Care | ▲ Double-digit secondary | Shampoo grew ~11% vs category 3%, entirely volume-led in sachets; bottles (20% of portfolio) driven by premium ingredients in modern trade and e-commerce. |
| Hair Oil | ▲ Share gain of 140 bps | Secular growth across coconut, perfume and cooling oils; Cool King attained ~3-4% relative share; only 16-17% category share leaves 80-85% headroom. |
| Home Care | ▲ ~7% growth | Odomos gained 1067 bps MRC to 65.2% share via format extension to oils, gels, LVPs; Odonil gained 180 bps share, extended to room formats and diffusers on Amazon. |
| Healthcare | ▬ 3% growth (YTD CAGR 8.3%) | Digestives grew 15% on Hajmola; Chyawanprash gained 151 bps share; Honey gained 33 bps; winter-delayed products muted. |
| Beverages | ▲ ~7% growth | Badshah grew 33% (volume 20-22%, pricing 9-10%) driven by focused marketing and rejuvenated portfolio. |
| International | ▲ 11.7% CC growth | Broad-based growth across markets. |
- Badshah growth vectors are still early: Distribution is expanding from West to North and South (Madhya Pradesh, Rajasthan); international business at 5-6% of Badshah sales could reach ~30%; gaps in Rs. 5 and Rs. 10 pack price architecture are being plugged; national advertising has not yet started.
- Odomos and Odonil transformed via format extension: Odomos moved from personal application creams to oils, gels and LVPs, expanding the addressable market; Odonil extended from toilet blocks to room air fresheners, gels, gel pockets, zipper pouches and diffusers.
- Therapeutic division building an allopathic bridge: A new advocacy vertical now details to allopathic doctors, not just Ayurvedic practitioners; the merged division (Pharma, branded ethical, Baby Care) is growing ~40-50%, with FY25 expected to bring significant new product launches and investment behind power brands.
Mohit Malhotra: "At the end of the day, we have only around 16%-17% market share. We see headroom of roughly around 80%-85% of the business there for us."
Margins & Cost Structure
- Gross margin expanded 310 bps on material deflation: Raw material prices remain benign with ~4% deflation in India and ~2% globally, concentrated in HPC categories (mustard oil, oils, LLP); some deflation will persist in Q4.
- A&P investment stepped up 36% as promised: Management is deploying gross margin upside into media to drive long-term sustainable growth, consistent with its stated strategy.
- Operating profit walk: Consolidated OP grew 9.5% with 50 bps margin improvement; excluding exceptional legal costs, OP grew 13% with 120 bps margin expansion. Other expenses excluding legal costs grew 10% in Q3 but only 4% YTD.
- Legal cost trajectory improving: New lawyers engaged at much lower fees effective October; FY24-25 legal cost will be lower than FY23-24; product liability insurance is in place and any recovery will flow as profit; current quarterly legal cost is ~Rs. 20 cr.
- Q4 margin seasonality and expansion promise: Q4 margins are structurally the lowest (Healthcare and food summer loading), but expansion will continue at a slightly faster pace than the 50 bps YTD including legal costs; management is making all efforts to reach the ~19.5% margin guidance.
Ankush Jain: "The margins are in our business pretty seasonal. The last quarter is heavier on certain product mix and hence it is lower. So, it can't be 20% even in Q4 and if you see our 3-4 years trajectory that has been the case. Q4 margins are the least while Q3 are the highest because we have Healthcare portfolio and so on and also some bit of expense phasing might happen, but I would summarize by saying that the expansion in margins will continue albeit at a slightly faster pace in Q4."
Distribution & Reach Expansion
- Direct reach target raised to 0.15 crore outlets by fiscal year-end, up 2 lakh outlets in the quarter.
- Village coverage expanding without pause: From 1,00,000 to 1,17,000 villages this year, targeted at 1.2 lakh going forward and 1.3 lakh next year; Yoddha network at 18,700 and still adding.
- Geographic rural strength concentrated in North and East: These are Dabur's rural-salient geographies; Badshah distribution is helping build rural presence in the West; South contributes ~20% of business and is not as strong for Dabur.
- Herbal toothpaste test-marketed in South India and will be rolled out across India, addressing a geographic gap.
Mohit Malhotra: "There are 6 lakh villages, we are barely reaching out to 1.10 lakh villages, we have targeted ourselves to go up for 1.2 lakh villages going forward. Next year it will be 1.3. So, we will keep adding the number of villages here and the Yodha network and the playbook like I was saying is already in place for us."
Legal & Regulatory Update
- Corporate separateness upheld by courts: The case is now restricted only to products sold in the US by the Namaste legal entity; any Dabur affiliate or Dabur products are out of scope; the impacted turnover is less than 1% of consolidated revenue.
- Legal cost visibility improving but timeline uncertain: New lawyers engaged at lower fees from October; FY24-25 cost will be lower than FY23-24; current quarterly cost is ~Rs. 20 cr; management did not provide a timeline for case resolution when asked.
- Insurance backstop in place: Product liability insurance covers legal costs; the company is currently providing for full legal costs conservatively, and any insurance recovery will be recognized as profit.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Foods portfolio exit run rate | Rs. 500 crores including Badshah | By fiscal year-end |
| Direct reach | Increase to 0.15 crore outlets | By fiscal year-end |
| Village coverage | Expand to 1.2 lakh villages | Going forward (1.3 lakh next year) |
| Operating margin | ~19.5% for the full year | FY24 |
| Q4 margin expansion | Faster pace than YTD 50 bps including legal costs | Q4 FY24 |
| Legal cost | Lower in FY24-25 than FY23-24 | FY24-25 |
| Oral Care premiumization | Initiatives in whitening, gum, sensitive segments | Next 2-5 years; a couple visible in the next year |
| Therapeutic division | Significant developments, new launches, ramp-ups, investment behind power brands | FY25 |
Key Metrics
| Metric | Q3 FY24 |
|---|---|
| Consolidated revenue | ₹3,255 cr, +7% YoY in INR terms, +9.6% in constant currency |
| India FMCG volume growth | 6% (including Badshah) |
| Gross margin expansion | 310 bps YoY |
| Operating margin (reported) | +50 bps YoY improvement; consolidated operating profit grew 9.5% |
| Operating margin (excl. legal costs) | +120 bps YoY expansion; operating profit grew 13% |
| Consolidated PAT growth (reported) | 8% YoY |
| Consolidated PAT growth (like-to-like, excl. legal costs) | 15% YoY |
| A&P investments | +36% YoY increase |
| International business constant currency growth | 11.7% |
| Oral Care portfolio growth | 8% value growth, 5% volume growth |
| Hair Oil market share | 17.1%, +140 bps YoY |
| Healthcare portfolio growth | 3% YoY; YTD CAGR 8.3% |
| Digestives category growth | 15% |
| Badshah business growth | 33% (volume ~20-22%, pricing ~9-10%) |
| Rural vs urban growth | Rural ~6-6.5%, urban ~3.8%; gap narrowed to ~200 bps |
| Village coverage | 1.17 lakh villages, supported by 18,700+ Yodhas |
| Direct reach | 0.14 crore outlets, +2 lakh outlets added |
| E-commerce contribution | ~8.5% of sales, +20% YoY growth |
| Therapeutic division revenue | ~₹95 cr in 9M FY24, ~₹35 cr per quarter run rate; YTD growth 21% |
| Legal costs (one-off) | ~₹20 cr incurred in the quarter |
| Price increase taken | ~2.5% MRP-led (including overlap) |
| Edge Score improvement | ~15% in the quarter |
| Odomos market share | 65.2%, +1067 bps in MRC category |
| Chyawanprash market share gain | +151 bps |
| Dabur Honey growth | 11% YoY; market share +33 bps |
| Shampoo growth | ~11% YoY, 15% CAGR over 4 years |
| Capex approved for South India plant | ₹135 cr |